Overview
John Frenzel is an Anesthesiologist in Cary, North Carolina. Dr. Frenzel is highly rated in 1 condition, according to our data. His top areas of expertise are Muscle Invasive Bladder Cancer and Non-Muscle Invasive Bladder Cancer.
His clinical research consists of co-authoring 3 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- HMO
- INDEMNITY
- POS
- PPO
Locations
210 Ashville Ave # 408, Cary, NC 27518
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UT MD Anderson Cancer Center
Farzin Goravanchi is an Anesthesiologist in Cary, North Carolina. Dr. Goravanchi is highly rated in 3 conditions, according to our data. His top areas of expertise are Upper Tract Urothelial Carcinoma (UTUC), Muscle Invasive Bladder Cancer, and Non-Muscle Invasive Bladder Cancer.
UT MD Anderson Cancer Center
Alicia Kowalski is an Anesthesiologist in Cary, North Carolina. Dr. Kowalski is highly rated in 1 condition, according to our data. Her top areas of expertise are Muscle Invasive Bladder Cancer and Non-Muscle Invasive Bladder Cancer.
UT MD Anderson Cancer Center
Jeffrey Cerny is an Anesthesiologist in Cary, North Carolina. Dr. Cerny is highly rated in 3 conditions, according to our data. His top areas of expertise are Non-Muscle Invasive Bladder Cancer, Muscle Invasive Bladder Cancer, Upper Tract Urothelial Carcinoma (UTUC), and T-Cell Lymphoma.
Frequently Asked Questions about Dr. John Frenzel
How do I make an appointment with Dr. John Frenzel?
You can book an appointment with Dr. John Frenzel by calling their office at 713-792-6161. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. John Frenzel a top-rated expert for Muscle Invasive Bladder Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. John Frenzel is classified as an Advanced expert for Muscle Invasive Bladder Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. John Frenzel specialize in?
While Dr. John Frenzel is a Anesthesiology, they have specific expertise in Muscle Invasive Bladder Cancer, Non-Muscle Invasive Bladder Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Anesthesiology.
Does Dr. John Frenzel participate in research or clinical trials?
Yes. Dr. John Frenzel has published 3 articles and abstracts on conditions like Muscle Invasive Bladder Cancer. You can view a list of Dr. John Frenzel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. John Frenzel accept my insurance?
Dr. John Frenzel accepts most major insurance plans, including Humana. We recommend calling the office directly at 713-792-6161 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Muscle Invasive Bladder CancerDr. Frenzel isAdvanced. Learn about Muscle Invasive Bladder Cancer.
- Experienced
- Non-Muscle Invasive Bladder CancerDr. Frenzel isExperienced. Learn about Non-Muscle Invasive Bladder Cancer.